Athanor Capital’s Pfizer PFE Stock Holding History

Athanor Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,872	Closed	-$518K	–	796
2020 Q3	$518K	Buy	14,872 +3,796	+34%	+$133K	0.02%	333
2020 Q2	$344K	Buy	+11,076	New	+$376K	0.02%	378
2020 Q1	–	Sell	-24,031	Closed	-$893K	–	294
2019 Q4	$893K	Buy	+24,031	New	+$856K	0.04%	175

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Athanor Capital's PFE Position: Q4 2020 in Review

Athanor Capital sold out of Pfizer (PFE) in Q4 2020, closing a stake of 14,872 shares — an estimated $518K sold.

Athanor Capital first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $893K in Q4 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Athanor Capital reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Athanor Capital sold 14,872 Pfizer shares in Q4 2020, an estimated $518K.
Athanor Capital first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
Athanor Capital's Pfizer position peaked at $893K in Q4 2019.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.